import type { Metadata } from "next";
import Link from "next/link";

export const metadata: Metadata = {
  title: "Semaglutide vs Tirzepatide: Which GLP-1 Is Right for You?",
  description:
    "Semaglutide and tirzepatide are both proven GLP-1 medications for weight loss. Here is a side-by-side comparison of mechanism, results, pricing, and which one may be right for your situation.",
};

const jsonLd = {
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  headline: "Semaglutide vs Tirzepatide: Which GLP-1 Is Right for You?",
  description:
    "Semaglutide and tirzepatide are both proven GLP-1 medications for weight loss. Here is a side-by-side comparison of mechanism, results, pricing, and which one may be right for your situation.",
  author: {
    "@type": "Organization",
    name: "Earth Angel Wellness",
    url: "https://earthangelwellness.com",
  },
  publisher: {
    "@type": "Organization",
    name: "Earth Angel Wellness",
    url: "https://earthangelwellness.com",
  },
  datePublished: "2026-03-25",
  dateModified: "2026-03-25",
  url: "https://earthangelwellness.com/blog/semaglutide-vs-tirzepatide",
  mainEntityOfPage: "https://earthangelwellness.com/blog/semaglutide-vs-tirzepatide",
};

export default function SemaglutideVsTirzepatidePage() {
  return (
    <>
      <script
        type="application/ld+json"
        dangerouslySetInnerHTML={{ __html: JSON.stringify(jsonLd) }}
      />

      {/* Hero */}
      <section className="bg-obsidian pt-32 pb-16 px-6 text-center">
        <p className="text-gold font-[family-name:var(--font-cormorant)] text-lg tracking-widest uppercase mb-4">
          GLP-1 Education
        </p>
        <h1 className="font-[family-name:var(--font-cormorant)] text-4xl md:text-6xl text-cream font-light leading-tight mb-6 max-w-4xl mx-auto">
          Semaglutide vs Tirzepatide: Which GLP-1 Is Right for You?
        </h1>
        <div className="flex items-center justify-center gap-4 text-cream/50 text-sm tracking-wide">
          <span>March 25, 2026</span>
          <span className="w-1 h-1 rounded-full bg-gold inline-block" />
          <span>Earth Angel Wellness</span>
        </div>
      </section>

      {/* Article Body */}
      <section className="bg-cream py-16 px-6">
        <article className="max-w-3xl mx-auto text-obsidian/80 leading-relaxed text-lg">

          {/* Intro */}
          <p className="mb-6">
            GLP-1 medications have rewritten what is possible in medical weight loss. Patients who
            spent decades struggling with conventional diets and exercise programs are losing 30, 40,
            even 50+ pounds under medically supervised GLP-1 protocols. The clinical evidence is
            solid. The results are real.
          </p>
          <p className="mb-10">
            The question most patients arrive with is not whether these medications work. It is which
            one is right for them. Semaglutide and tirzepatide are both excellent options, but they
            are not identical. Here is what you need to know to have an informed conversation with
            your provider.
          </p>

          {/* What Are GLP-1 Medications */}
          <h2 className="font-[family-name:var(--font-cormorant)] text-3xl text-obsidian font-light leading-snug mb-4 mt-10">
            What Are GLP-1 Medications?
          </h2>
          <p className="mb-6">
            GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces after
            eating. It signals your brain that you are full, slows the rate at which your stomach
            empties, and helps regulate insulin release in response to blood sugar.
          </p>
          <p className="mb-10">
            GLP-1 receptor agonists mimic this hormone at a much higher concentration and for a
            much longer duration than your body can produce on its own. The result is reduced
            appetite, better blood sugar control, and, for most patients, significant and sustained
            weight loss. Both semaglutide and tirzepatide work through this pathway, though they do
            it differently.
          </p>

          {/* Semaglutide */}
          <h2 className="font-[family-name:var(--font-cormorant)] text-3xl text-obsidian font-light leading-snug mb-4 mt-10">
            Semaglutide: The Proven Standard
          </h2>
          <p className="mb-6">
            Semaglutide is a GLP-1 receptor agonist, meaning it binds specifically to GLP-1
            receptors in the brain and digestive system. It reduces hunger signals, slows gastric
            emptying, and improves insulin sensitivity. Clinical trials in the STEP program showed
            an average of around 35 lbs of weight loss over 68 weeks at the highest dose.
          </p>
          <p className="mb-6">
            It is administered as a once-weekly subcutaneous injection, typically starting at a low
            dose and titrating up over several months to minimize nausea and other early side
            effects.
          </p>
          <p className="mb-10">
            At Earth Angel Wellness, semaglutide is priced at{" "}
            <strong className="text-obsidian">$399 per four-week supply</strong>. For patients who
            want a proven, well-studied protocol with a strong clinical track record, it is an
            excellent starting point. You can learn more on our{" "}
            <Link href="/services/weight-loss-injections" className="text-gold hover:text-gold/70 underline underline-offset-2 transition-colors">
              weight loss injections page
            </Link>
            .
          </p>

          {/* Tirzepatide */}
          <h2 className="font-[family-name:var(--font-cormorant)] text-3xl text-obsidian font-light leading-snug mb-4 mt-10">
            Tirzepatide: The Dual-Action Option
          </h2>
          <p className="mb-6">
            Tirzepatide adds a second mechanism to the equation. In addition to activating GLP-1
            receptors, it also activates GIP receptors (glucose-dependent insulinotropic
            polypeptide). GIP is another gut hormone involved in insulin regulation and fat
            metabolism. Hitting both pathways simultaneously appears to produce stronger appetite
            suppression and greater average weight loss than GLP-1 alone.
          </p>
          <p className="mb-6">
            Clinical trials in the SURMOUNT program showed average weight loss of approximately 20
            to 22 percent of body weight at the highest dose, which is meaningfully higher than
            semaglutide-only trials. For a 250-pound patient, that could represent 50+ lbs of loss.
          </p>
          <p className="mb-10">
            At Earth Angel Wellness, tirzepatide is priced at{" "}
            <strong className="text-obsidian">$460 per four-week supply</strong>. The added cost
            reflects the more complex dual-receptor mechanism and, for many patients, the stronger
            results.
          </p>

          {/* Comparison Table */}
          <h2 className="font-[family-name:var(--font-cormorant)] text-3xl text-obsidian font-light leading-snug mb-6 mt-10">
            Side-by-Side Comparison
          </h2>
          <div className="overflow-x-auto mb-10 rounded-xl shadow-sm">
            <table className="w-full text-sm text-obsidian border-collapse">
              <thead>
                <tr className="bg-obsidian text-cream">
                  <th className="text-left px-5 py-4 font-semibold tracking-wide">Feature</th>
                  <th className="text-left px-5 py-4 font-semibold tracking-wide">Semaglutide</th>
                  <th className="text-left px-5 py-4 font-semibold tracking-wide">Tirzepatide</th>
                </tr>
              </thead>
              <tbody>
                <tr className="bg-white border-b border-obsidian/10">
                  <td className="px-5 py-4 font-medium text-obsidian">Mechanism</td>
                  <td className="px-5 py-4">GLP-1 receptor agonist</td>
                  <td className="px-5 py-4">Dual GLP-1 and GIP receptor agonist</td>
                </tr>
                <tr className="bg-cream/60 border-b border-obsidian/10">
                  <td className="px-5 py-4 font-medium text-obsidian">Receptor Targets</td>
                  <td className="px-5 py-4">GLP-1 only</td>
                  <td className="px-5 py-4">GLP-1 + GIP</td>
                </tr>
                <tr className="bg-white border-b border-obsidian/10">
                  <td className="px-5 py-4 font-medium text-obsidian">Typical Results</td>
                  <td className="px-5 py-4">Avg. ~35 lbs over 68 weeks</td>
                  <td className="px-5 py-4">Avg. 20-22% body weight loss</td>
                </tr>
                <tr className="bg-cream/60 border-b border-obsidian/10">
                  <td className="px-5 py-4 font-medium text-obsidian">Pricing at Earth Angel</td>
                  <td className="px-5 py-4">$399 per 4 weeks</td>
                  <td className="px-5 py-4">$460 per 4 weeks</td>
                </tr>
                <tr className="bg-white border-b border-obsidian/10">
                  <td className="px-5 py-4 font-medium text-obsidian">Administration</td>
                  <td className="px-5 py-4">Once-weekly injection</td>
                  <td className="px-5 py-4">Once-weekly injection</td>
                </tr>
                <tr className="bg-cream/60">
                  <td className="px-5 py-4 font-medium text-obsidian">Clinical Track Record</td>
                  <td className="px-5 py-4">Extensive (STEP trials)</td>
                  <td className="px-5 py-4">Strong and growing (SURMOUNT trials)</td>
                </tr>
              </tbody>
            </table>
          </div>

          {/* Which Is Right For You */}
          <h2 className="font-[family-name:var(--font-cormorant)] text-3xl text-obsidian font-light leading-snug mb-4 mt-10">
            Which One Is Right for You?
          </h2>
          <p className="mb-6">
            There is no universal answer, which is exactly why the choice gets made with a provider
            rather than a quiz. That said, here are the factors your provider will consider.
          </p>
          <p className="mb-4">
            <strong className="text-obsidian">Amount of weight to lose.</strong> Patients with
            higher starting weights and larger weight loss goals often see greater benefit from
            tirzepatide due to the stronger average results in clinical studies.
          </p>
          <p className="mb-4">
            <strong className="text-obsidian">Blood sugar and metabolic health.</strong> Tirzepatide
            has particularly strong data for patients with insulin resistance or type 2 diabetes. If
            your labs show elevated blood sugar, your provider may lean toward tirzepatide.
          </p>
          <p className="mb-4">
            <strong className="text-obsidian">Budget.</strong> The $61 per month difference between
            the two medications is meaningful over a full program. If cost is a primary concern,
            semaglutide delivers excellent results at a lower price point. Both medications are also
            eligible for{" "}
            <Link href="/financing" className="text-gold hover:text-gold/70 underline underline-offset-2 transition-colors">
              financing through Cherry and CareCredit
            </Link>
            .
          </p>
          <p className="mb-10">
            <strong className="text-obsidian">Prior GLP-1 experience.</strong> Some patients who
            have previously tried semaglutide without achieving their target results switch to
            tirzepatide for the added GIP mechanism. This can be a productive path when semaglutide
            alone has plateaued.
          </p>

          {/* Side Effects */}
          <h2 className="font-[family-name:var(--font-cormorant)] text-3xl text-obsidian font-light leading-snug mb-4 mt-10">
            Side Effects and How to Manage Them
          </h2>
          <p className="mb-6">
            Both medications share a similar side effect profile, which is expected given they both
            work on GLP-1 receptors. The most common side effects are nausea, mild headache, and
            occasional fatigue, particularly in the first few weeks after a dose increase.
          </p>
          <p className="mb-6">
            The reason protocols start low and titrate up slowly is specifically to reduce these
            early side effects. Most patients find them manageable and temporary. Strategies that
            help include eating smaller meals, avoiding high-fat foods especially in the early
            weeks, staying well hydrated, and not eating too close to injection time.
          </p>
          <p className="mb-10">
            If side effects are more than mild, your provider can slow the titration schedule. There
            is no benefit to pushing through a dose that is making you miserable. A slower ramp is
            always an option, and it does not meaningfully change long-term outcomes.
          </p>

          {/* CTA */}
          <div className="bg-obsidian rounded-2xl p-8 text-center mt-12">
            <h2 className="font-[family-name:var(--font-cormorant)] text-3xl text-cream font-light mb-4">
              Not Sure Which to Choose?
            </h2>
            <p className="text-cream/70 mb-6 max-w-xl mx-auto">
              That is what the free consultation is for. Book a call with our team and we will
              review your health history, goals, and budget to recommend the right protocol.
            </p>
            <Link
              href="https://www.myaestheticspro.com/BN/index.cfm?A1ADC6216482A474E49936A5127F073FF16AC4C3ED8430234F8EBFA67C25B884"
              target="_blank"
              rel="noopener noreferrer"
              className="inline-block bg-gold text-obsidian font-semibold tracking-wider uppercase text-sm px-10 py-4 rounded-full hover:bg-gold/90 transition-colors"
            >
              Book Your Free Consultation
            </Link>
          </div>
        </article>
      </section>
    </>
  );
}
